Agnosia
Symptoms, Doctors, Treatments, Advances & More

Agnosia Overview

Save information for later
Sign Up

Learn About Agnosia

What is the definition of Agnosia?
Agnosia is characterized by an inability to recognize and identify objects and/or persons. Symptoms may vary, according to the area of the brain that is affected. It can be limited to one sensory modality such as vision or hearing; for example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, traumatic brain injury, dementia, a tumor, developmental disorders, overexposure to environmental toxins (e.g., carbon monoxide poisoning), or other neurological conditions. Visual Agnosia may also occur in association with other underlying disorders. People with Agnosia may retain their cognitive abilities in other areas.
What are the alternative names for Agnosia?
  • Agnosia
  • Monomodal visual amnesia
  • Primary visual agnosia
  • Visual amnesia
Who are the top Agnosia Local Doctors?
Elite in Agnosia
Dr. Gad A. Marshall
Neurology
Elite in Agnosia
Dr. Gad A. Marshall
Neurology

Brigham And Women's Hospital, Neurosciences Center

60 Fenwood Road, 1st Floor Hale Building For Transformative Medicine, 
Boston, MA 
617-539-7286
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gad Marshall is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Marshall is rated as an Elite provider by MediFind in the treatment of Agnosia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Agnosia, Alzheimer's Disease, Dementia, and Memory Loss. Dr. Marshall is board certified in Neurology.

Elite in Agnosia
Jason J. Barton
Elite in Agnosia
Jason J. Barton
2550 Willow Street, 
Vancouver, BC, CA 

Jason Barton practices practicing medicine in Vancouver, Canada. Mr. Barton is rated as an Elite expert by MediFind in the treatment of Agnosia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Agnosia, Concussion, Auditory Neuropathy Spectrum Disorder, and Auditory Processing Disorder.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Agnosia
Sherryse L. Corrow
Elite in Agnosia
Sherryse L. Corrow
Vancouver, BC, CA 

Sherryse Corrow practices practicing medicine in Vancouver, Canada. Corrow is rated as an Elite expert by MediFind in the treatment of Agnosia. They are also highly rated in 1 other condition, according to our data. Their clinical expertise encompasses Agnosia, Auditory Neuropathy Spectrum Disorder, Auditory Processing Disorder, and Color Blindness.

View All Doctors
What are the latest Agnosia Clinical Trials?
Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease
Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease
Enrollment Status: Recruiting
Publish Date: April 15, 2026
Intervention Type: Behavioral

Summary: This monocentric, non-interventional study (SELFSOC) investigates the relationship between self-awareness and social cognition in patients with behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD). The primary objective is to assess metacognitive efficiency related to social cognitive performance using a computerized facial emotion recognition task combined with confiden...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Continuous Infusion Versus Intermittent Ketorolac for Postoperative Pain Control in Pediatric Cardiac Surgery Patients
Continuous Infusion Versus Intermittent Ketorolac for Postoperative Pain Control in Pediatric Cardiac Surgery Patients
Who is this study for: Patients aged 3 months to 4 years undergoing cardiac surgery
Enrollment Status: Recruiting
Publish Date: January 23, 2026
Intervention Type: Drug
Study Drug: Ketorolac
Study Phase: Phase 4

Summary: The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center